Brief: Achilles Therapeutics Announces Grant Of US Patent On Immunotherapies Targeting Clonal Neoantigens Identified Using Proprietary Method
22/11/2022 13:16
Nov 22 (Reuters) - Achilles Therapeutics PLC 698y.F :
* ACHILLES THERAPEUTICS ANNOUNCES GRANT OF US PATENT ON
IMMUNOTHERAPIES TARGETING CLONAL NEOANTIGENS IDENTIFIED USING
PROPRIETARY METHOD
Source text for Eikon: ID:nGNX1LxJrq
Further company coverage: 698y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Achilles Therapeutics
See all newsBrief: Achilles Therapeutics Announces Sale Of Technology Assets To Astrazeneca
Brief: Achilles Therapeutics Receives Approval To Transfer To Nasdaq Capital Market
Achilles gains on plans to explore strategic options
Brief: Achilles Therapeutics To Discontinue Development Of TIL-Based cNET Therapy
Brief: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement